Annual report pursuant to Section 13 and 15(d)

INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details)

v3.24.2.u1
INCOME TAXES - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2024
Jun. 30, 2023
Deferred tax assets:    
Capitalized R&D expenses $ 328,061 $ 201,228
Tax credits and net operating losses 311,026 271,500
Depreciation and amortization 151,371 73,691
Inventory reserves 121,238 103,646
Employee benefits accrual 95,461 92,696
Non-deductible reserves 53,668 52,147
Unearned revenue 25,532 16,668
SBC 15,375 12,710
Other 12,785 35,360
Gross deferred tax assets 1,114,517 859,646
Valuation allowance (289,534) (259,172)
Net deferred tax assets 824,983 600,474
Deferred tax liabilities:    
Unremitted earnings of foreign subsidiaries not indefinitely reinvested (315,231) (279,677)
Deferred profit (70,204) (23,149)
Unrealized gain on investments (10,949) (9,994)
Total deferred tax liabilities (396,384) (312,820)
Total net deferred tax assets $ 428,599 $ 287,654